Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
LXH254 Combination for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing a new drug (LXH254) combined with other existing drugs to find a safe and effective dose for cancer patients who need new treatment options. The drugs work by blocking signals that cancer cells use to grow.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service